Bladder cancer — all decisions

The Board remanded the claims for service connection for bladder cancer and lung disease to correct errors in assessing toxic exposures during service.

The Board granted the veteran's appeal and restored the 100 percent rating for bladder cancer, finding that the reduction was improper because the cancer remained active and malignant.

The veteran was granted a 60% rating for bladder cancer with voiding dysfunction and a total disability rating based on individual unemployability (TDIU).

The veteran's claims for service connection for hypertension, hypertensive heart disease, chronic kidney disease, and anemia were granted. The claims for bladder cancer, erectile dysfunction, gouty arthropathy were denied. The claim for transient ischemic attack was remanded.

The Board denied service connection for bladder cancer, lung cancer, and teeth loss secondary to chemotherapy. The evidence did not show these conditions were related to the veteran's military service.

The veteran's appeals for higher ratings and earlier effective dates for bladder cancer and hypothyroidism were dismissed because the veteran withdrew the appeals.

The Board remanded the claim for service connection of a urinary tract condition, including bladder cancer. The Veteran's case will be reviewed again with new evidence considered.

The veteran's service connection for bladder cancer is granted based on presumed exposure to herbicide agents during his service in Korea.

The Board granted the Veteran's appeal, finding that the severance of service connection for bladder cancer, prostate cancer, kidney disease, scars, and hypertension was improper. The Board also granted the appeal for the severance of Special Monthly Compensation (SMC) based on statutory housebound and Dependents' Educational Assistance (DEA).

The veteran's effective date for a 40% rating of bladder cancer is granted as December 1, 2018. The effective date for service connection of erectile dysfunction is January 5, 2011.

The Board remanded the claims for service connection for a bowel condition and a compensable rating for residuals of bladder cancer due to new and relevant evidence.

The veteran's claim for an earlier effective date for bladder cancer service connection was denied. However, the veteran was granted a 100% disability rating from October 20, 2014 through August 31, 2020, and a 40% rating from September 1, 2020 through January 26, 2022. Additionally, special monthly compensation at the housebound rate was granted for the period from October 20, 2014 through August 31, 2020.

The veteran is granted a 10% disability rating for rhinitis but denied a compensable rating for bladder cancer.

Service connection for recurrent low grade bladder cancer is granted based on presumptive exposure to herbicide agents during service in Vietnam.

The veteran's claim for an earlier effective date for bladder cancer due to herbicide agent exposure was granted, but the request for a higher rating was denied.

The case is remanded to obtain missing medical records relevant to the veteran's bladder cancer rating from December 1, 2015.

The veteran's appeal for a higher rating for bladder cancer residuals was granted. The Board awarded an initial 20 percent rating effective August 10, 2022.

The Board remands the claims for service connection for various cancers and conditions, including kidney cancer, bladder cancer, mucosa associated lymphoid tissue lymphoma, prostate cancer, chronic lymphocytic leukemia/small lymphocytic leukemia, peripheral neuropathy, a degenerative spine condition, and heart arrhythmia, to obtain additional medical opinions regarding their relationship to the Veteran's in-service toxic exposure risk activities.

The claims for service connection for bladder cancer and diabetes mellitus, type II are remanded for further development.

The Board granted service connection for ischemic heart disease and diabetes mellitus type 2, dismissed the appeal for bladder cancer, and remanded claims for right upper extremity peripheral neuropathy and left upper extremity peripheral neuropathy.